Xarelto Approved for Prevention of DVT - ONA
Links shared publicly online about this topic.
- 169total visits
Xarelto Approved for Prevention of DVT - ONA
View full resource at oncologynurseadvisor.com
Tags: Circulatory Disorders, Deep Venous Thrombosis, Thrombotic Event, Pharma, FDA, Anti-Clotting Medication, Xarelto
Most Recently Shared on July 5, 2011 at 4:00 pm By:
Xarelto Approved for Prevention of DVT http://goo.gl/fb/nClF6
A VERY HAPPY NEW YEAR TO OUR SHU FOLLOWERS! PART 1 OF “WHAT HAPPENED TO YOUR HEART IN 2011?” Advice Information Review SmarterHeartUniversity.com Radio
smarterheartuniversity.com — “A VERY HAPPY NEW YEAR TO OUR SHU FOLLOWERS! PART 1 OF “WHAT HAPPENED TO YOUR HEART IN 2011?” Advice Information Review SmarterHeartUniversity.com Radio” View full resource at smarterheartuniversity.com
Most Recently Shared on January 2, 2012 at 8:22 pm By:
Letter to FDA Opposing Approval of Rivaroxaban (Xarelto) for Anticoagulation Therapy in Patients With Atrial Fibrillation
citizen.org — “Letter to FDA Opposing Approval of Rivaroxaban (Xarelto) for Anticoagulation Therapy in Patients With Atrial Fibrillation” View full resource at citizen.org
Most Recently Shared on November 8, 2011 at 6:19 pm By:
Sidney Wolfe, MD Physician, Doctor, and Internist
@US_FDA ignores @Public_Citizen and expands Xarelto use to prevent strokes. See the letter we sent to the FDA. http://t.co/Qctgd29G
FDA approves #warfarin alternative #rivaroxaban (#Xarelto) for atrial fibrillation #stroke prevention: http://t.co/GWrzoOcO #afib
stopafib.org — “FDA approves #warfarin alternative #rivaroxaban (#Xarelto) for atrial fibrillation #stroke prevention: http://t.co/GWrzoOcO #afib” View full resource at stopafib.org
Most Recently Shared on November 7, 2011 at 1:16 pm By:
FDA approves #warfarin alternative #rivaroxaban (#Xarelto) for atrial fibrillation #stroke prevention: http://t.co/GWrzoOcO #afib
Janssen receives FDA approval for Xarelto to prevent stroke in people with AF
news-medical.net — “The U.S. Food and Drug Administration today approved the anti-clotting drug Xarelto (rivaroxaban) to reduce the risk of stroke in people who have abnormal heart rhythm.” View full resource at news-medical.net
Most Recently Shared on November 5, 2011 at 7:04 am By:
Janssen receives FDA approval for Xarelto to prevent stroke in people with AF: The U.S. Food and Drug Administra... http://t.co/pc8sNEsq
Xarelto Approved for Atrial Fib Patients
webmd.com — “The FDA has approved Janssen's Xarelto to prevent stroke in patients with atrial fibrillation -- with a strong black box warning.” View full resource at webmd.com
Most Recently Shared on November 4, 2011 at 10:48 pm By:
Xarelto Approved for Atrial Fib Patients: The FDA has approved Janssen's Xarelto to prevent stroke in patients w... http://t.co/vs95V0gP
FDA Overrules Staff Analysis in Approving Anticlotting Drug - WSJ.com
online.wsj.com — “The FDA approved the latest in a class of new anticlotting drugs to prevent stroke—Xarelto from Johnson & Johnson and Bayer—but overruled its own staff's analysis in doing so.” View full resource at online.wsj.com
Most Recently Shared on November 4, 2011 at 10:15 pm By:
Eric Topol, MD Cardiologist, Physician, Doctor, and Internist
A controversial anti-clotting drug gets FDA approval...http://on.wsj.com/v7TwJB
FDA Okays Xarelto for Stroke Prevention - ABC News
abcnews.go.com — “The FDA has approved rivaroxaban (Xarelto) for prevention of stroke in patients with nonvalvular atrial fibrillation.” View full resource at abcnews.go.com
Most Recently Shared on November 4, 2011 at 8:11 pm By:
Tom Heston, MD Physician, Doctor, and Family Medicine Doctor
FDA Okays Xarelto for Stroke Prevention - ABC News http://t.co/u3b73w1x #health
FDA panel votes 9-2 in favor of new blood thinner drug
news-medical.net — “A new stroke preventer from Bayer and Johnson & Johnson – Xarelto moved one step closer to U.S. approval, but questions remained about restrictions on labeling and the need for more studies.” View full resource at news-medical.net
Most Recently Shared on September 10, 2011 at 1:56 am By:
Drugs and Devices OW OW Health
FDA panel votes 9-2 in favor of new blood thinner drug - News-Medical.net: USA TodayFDA panel votes 9-2 in... http://t.co/Y0EipDF #drug
Medical News: Panel Endorses Xarelto for Stroke Prevention - in Cardiovascular, Strokes from MedPage Today
medpagetoday.com — “ADELPHI, Md. -- An FDA advisory committee has voted 9-2, with one abstention, to recommend that the FDA approve the direct oral factor Xa inhibitor rivaroxaban (Xarelto) to prevent stroke in patients” View full resource at medpagetoday.com
Most Recently Shared on September 9, 2011 at 8:23 pm By:
Marya Zilberberg, MD Doctor, Internist, and Physician
Advisory Committee votes 9:2 to approve rivaroxaban in AF, despite trashing by the FDA earlier in the week http://t.co/XlKSBXA
J&J's blockbuster hopeful Xarelto bounces back with AdComm backing - FierceBiotech
fiercebiotech.com — “The blood thinner Xarelto came through an FDA advisory committee meeting looking better than some had expected. The AdComm backed approval of the potential blockbuster for preventing stokes in Read more...” View full resource at fiercebiotech.com
Most Recently Shared on September 9, 2011 at 1:05 pm By:
J&J's blockbuster hopeful Xarelto bounces back with AdComm backing http://t.co/WzCE9Oz
Bayer, J&J Blood Thinner Gets FDA Panel Backing For New Indication
rttnews.com — “Blood thinner Xarelto, co-developed by Bayer HealthCare, a subsidiary of German chemical and pharmaceutical giant Bayer AG (BYR.L) (BAYRY.PK) and Johnson & Johnson (JNJ) won an FDA expert panel vote Thursday, backing the approval of the drug for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation in the U.” View full resource at rttnews.com
Most Recently Shared on September 9, 2011 at 12:28 pm By:
Drugs and Devices OW OW Health
Bayer, J&J Stroke Drug Gets FDA Panel Backing - RTT News: USA TodayBayer, J&J Stroke Drug Gets FDA Panel B... http://t.co/ruIUBoN #drug
Medical News: Panel Endorses Xarelto for Stroke Prevention - in Cardiovascular, Strokes from MedPage Today
medpagetoday.com — “ADELPHI, Md. -- An FDA advisory committee has voted 9-2, with one abstention, to recommend that the FDA approve the direct oral factor Xa inhibitor rivaroxaban (Xarelto) to prevent stroke in patients” View full resource at medpagetoday.com
Most Recently Shared on September 9, 2011 at 12:42 am By:
Patricia Grace Eldercare Expert
Panel Endorses Xarelto for Stroke Prevention: ADELPHI, Md. (MedPage Today) -- An FDA advisory committee has vote... http://t.co/DVjOwXC
Medical News: Panel Endorses Xarelto for Stroke Prevention - in Cardiovascular, Strokes from MedPage Today
medpagetoday.com — “ADELPHI, Md. -- An FDA advisory committee has voted 9-2, with one abstention, to recommend that the FDA approve the direct oral factor Xa inhibitor rivaroxaban (Xarelto) to prevent stroke in patients” View full resource at medpagetoday.com
Most Recently Shared on September 8, 2011 at 11:57 pm By:
Panel Endorses Xarelto for Stroke Prevention http://t.co/d7Fbt73
Panel Endorses Xarelto for Stroke Prevention - QualityPoint Technologies
qualitypointtech.net — “ADELPHI, Md. (MedPage Today) -- An FDA advisory committee has voted 9-2, with one abstention, to recommend that the FDA approve the direct oral factor Xa inhibitor rivaroxaban (Xarelto) to prevent stroke in patients with nonvalvular atrial fibrillation.” View full resource at qualitypointtech.net
Most Recently Shared on September 8, 2011 at 11:45 pm By:
Panel Endorses Xarelto for Stroke Prevention: ADELPHI, Md. (MedPage Today) -- An FDA advisory committee has voted ... http://t.co/LirKpWx
FDA Recommends Against Bayer and J&J Anti-Clot Drug
ibtimes.com — “The Food and Drug Administration has recommended against an immediate approval for Bayer AG and Johnson & Johnson’s anti-clotting drug, Xarelto, as a treatment to prevent strokes in patients with atrial fibrillation.” View full resource at ibtimes.com
Most Recently Shared on September 7, 2011 at 5:25 am By:
FDA Recommends Against Bayer and J&J Drug http://t.co/ZayOjki
Advertisement
